{"editorial":{"content_id":"6717259b-7935-41f3-b975-2bcb91ad4179","slug":"anvisa-20261112-5291cc","content_type":"news","title":"巴西Anvisa第21次公开会议取消现场审议，三项监管议题撤出议程","summary":"巴西国家卫生监督局（Anvisa）2026年第21次董事会公开会议取消现场审议程序，原议程三项监管审议事项被撤出，其余事项改为数字审议。","body":"巴西国家卫生监督局（Anvisa）2026年第21次董事会公开会议原定于本周二（11月10日）举行，但将不设现场审议程序。原议程中的三项监管审议事项已被撤出议程。\n\n据Anvisa说明，随着上述三项议题撤出，议程中所有其余事项将通过数字审议程序处理。因此，会议既不设现场程序，也不进行转播。\n\nAnvisa表示，通过数字审议程序作出的决定将在投票结束后公布。","why_it_matters":null,"cbi_observation":null,"direction_tag":"巴西","primary_category":"科技平台","secondary_topics":["政策","合规","br-health"],"content_level":"编辑整理","event_type":"政策法规","audience_tags":[],"event_location":null,"verification_status":"original_checked","published_at":"2026-11-12T11:02:07.667Z","display_date":"2026-11-12","source_published_at":null,"source_url":"https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2026/reuniao-publica-da-diretoria-colegiada-da-anvisa-nao-tera-rito-presencial","source_name":"Anvisa","source_language":"pt","author_name":"编辑部","risk_level":"low","risk_flags":["regulatory_uncertainty","compliance_risk"],"opportunity_flags":[],"trend_signals":["regulatory_process_digitalization"]},"intelligence":{"intel_id":"8a8e9410-54b1-48b9-bb0d-8fcf738bfc1d","version":1,"event_type":"监管表态","event_date":"2026-11-10","main_entities":[{"name":"Anvisa","role":"巴西国家卫生监督局，会议主办与议程调整方","type":"regulator","country":"巴西","normalized_name":null}],"main_action":"Anvisa取消第21次公开会议现场审议，三项监管议题撤出并转数字审议","key_numbers":[{"unit":"次","label":"会议届次","value":"21"},{"unit":"项","label":"撤出监管审议事项","value":"3"}],"facts":[{"verified":false,"statement":"Anvisa 2026年第21次董事会公开会议原定于2026年11月10日（周二）举行。","source_excerpt":null},{"verified":false,"statement":"该会议不设现场审议程序，也不进行转播。","source_excerpt":null},{"verified":false,"statement":"原议程中的三项监管审议事项已被撤出议程。","source_excerpt":null},{"verified":false,"statement":"议程其余事项将通过数字审议程序处理，决定在投票结束后公布。","source_excerpt":null}],"assessments":[{"statement":"三项议题撤出且取消现场审议，可能增加相关监管事项的时间与结果不确定性。","confidence":"medium","basis_fact_index":null},{"statement":"其余事项转数字审议表明Anvisa仍维持议程推进，但外部实时观察渠道减少。","confidence":"medium","basis_fact_index":null},{"statement":"若撤出议题涉及平台或医疗科技合规，则相关企业短期合规安排可能需观望。","confidence":"low","basis_fact_index":null}],"actions":[{"target":"both","priority":"high","description":"跟进Anvisa数字审议投票结果及三项撤出议题的后续安排。"},{"target":"both","priority":"normal","description":"核实取消现场审议和转播的具体原因及是否影响法定程序。"},{"target":"user","priority":"normal","description":"排查三项撤出议题是否涉及在巴西运营的医疗健康或科技平台企业。"}],"affected_audience":["在巴西运营的医疗健康与科技平台企业","监管合规与公共事务团队","关注Anvisa议程的投资者","巴西卫生监管相关行业参与者"],"risk_flags":["regulatory_uncertainty","compliance_risk"],"opportunity_flags":[],"trend_signals":["regulatory_process_digitalization"],"follow_up_needed":true,"follow_up_questions":["三项被撤出的监管审议议题具体是什么，何时重新审议？","取消现场审议和转播的具体原因是什么？","数字审议投票结果预计何时公布？"],"related_topics":["Anvisa","巴西卫生监管","董事会公开会议","数字审议","监管议程"],"verification_status":"unverified","confidence_score":0.7,"generated_at":"2026-11-12T11:02:24.954Z"},"meta":{"canonical_url":"https://chinabrazilinsight.com/news/anvisa-20261112-5291cc","api_url":"https://chinabrazilinsight.com/api/public/content/anvisa-20261112-5291cc","markdown_url":"https://chinabrazilinsight.com/api/public/content/anvisa-20261112-5291cc?view=markdown","json_url":"https://chinabrazilinsight.com/api/public/content/anvisa-20261112-5291cc?view=json","last_updated":"2026-11-12T11:02:25.029Z","platform":"China Brazil Insight","platform_url":"https://chinabrazilinsight.com"}}